<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Immunotherapy Benefits Last</title><link>http://articles.mercola.com/sites/articles/archive/2008/01/02/immunotherapy-benefits-last.aspx</link><description>Experts estimate that up to 20% of adults suffer from allergic rhinitis, or hay fever. Long-term immunotherapy for the treatment of common allergies involves 'desensitizing' patients by injecting them with tiny amounts of the allergen. Now, researchers</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>